Ligand-Dependent Regulation of Vascular Endothelial Growth Factor and Erythropoietin Expression by a Plasmid-Based Autoinducible GeneSwitch System
Open Access
- 30 September 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 2 (3) , 276-287
- https://doi.org/10.1006/mthe.2000.0115
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Intramyocardial Gene Therapy with Naked DNA Encoding Vascular Endothelial Growth Factor Improves Collateral Flow to Ischemic MyocardiumHuman Gene Therapy, 1999
- Ligand-Dependent Regulation of Plasmid-Based Transgene Expression in VivoHuman Gene Therapy, 1999
- Electropermeabilization of skeletal muscle enhances gene transfer in vivoGene Therapy, 1999
- Intratracheal Administration of Interleukin 12 Plasmid-Cationic Lipid Complexes Inhibits Murine Lung MetastasesHuman Gene Therapy, 1999
- Vascular Endothelial Growth Factor Tightly Regulates In Vivo Development of Murine Hepatocellular Carcinoma CellsHepatology, 1998
- Inducible long-term gene expression in brain with adeno-associated virus gene transferGene Therapy, 1998
- Drug inducible transgene expression in brain using a herpes simplex virus vectorGene Therapy, 1998
- Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory systemGene Therapy, 1998
- Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulatorGene Therapy, 1997
- The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptorCell, 1992